Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

110.50
-0.0338-0.03%
Post-market: 110.500.00000.00%19:30 EDT
Volume:108.64K
Turnover:12.04M
Market Cap:1.00B
PE:89.54
High:111.36
Open:110.76
Low:110.19
Close:110.53
52wk High:118.00
52wk Low:85.91
Shares:9.09M
Float Shares:9.09M
Volume Ratio:0.54
T/O Rate:1.20%
Dividend:2.18
Dividend Rate:1.97%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):142.31

Loading ...

Novartis: More Pain on the Way?

Dow Jones
·
Sep 12

Sector Update: Healthcare

MT Newswires Live
·
Sep 12

Novo Nordisk Shares Fall After Morgan Stanley Downgrade

MT Newswires Live
·
Sep 12

Sector Update: Healthcare Stocks Ease in Afternoon Trading

MT Newswires Live
·
Sep 12

AbbVie Announces Q4 2026 Dividend of R$ 0.37 Per Unit, Payable Nov. 23

Reuters
·
Sep 12

DBS Keeps Their Buy Rating on Merck & Company (MRK)

TIPRANKS
·
Sep 12

AbbVie’s ECLIPSE Migraine Trial Completes, Setting Up a New Catalyst for ABBV

TIPRANKS
·
Sep 12

Novartis AG Falls Friday, Underperforms Market

Dow Jones
·
Sep 12

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 12

Eli Lilly Stock (LLY) in Focus as Company Completes $3.8 Billion AtaiBeckley Purchase

TIPRANKS
·
Sep 11

Eli Lilly Completes Acquisition of AtaiBeckley

Reuters
·
Sep 11

Lilly Completes Acquisition of Ataibeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions

THOMSON REUTERS
·
Sep 11

Analysts’ Top Healthcare Picks: Adagene (ADAG), AbbVie (ABBV)

TIPRANKS
·
Sep 11

U.S. Stocks on the MOVE-Novo Nordisk, Oracle, Adobe

Reuters
·
Sep 11

Berenberg Lifts Price Target on Merck to $137 From $127, Keeps Hold Rating

MT Newswires Live
·
Sep 11

Fosun Pharma's Subsidiary Sees Regulatory Acceptance for Denosumab Biosimilar Candidate HLX14

Stock News
·
Sep 11

Novo Nordisk Stock (NVO) Falls After Morgan Stanley’s Sell Call on Market Share Loss to Eli Lilly, Patent Cliff

TIPRANKS
·
Sep 11

Novo Nordisk downgraded to Underweight from Equal Weight at Morgan Stanley

TIPRANKS
·
Sep 11

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)

TIPRANKS
·
Sep 11

Novartis Needs to Make Progress on Pipeline to Justify Valuation

Dow Jones
·
Sep 11